Safety and efficacy of sucroferric oxyhydroxide in pediatric patients with chronic kidney disease

BACKGROUND: Pediatric patients with advanced chronic kidney disease (CKD) are often prescribed oral phosphate binders (PBs) for the management of hyperphosphatemia. However, available PBs have limitations, including unfavorable tolerability and safety. METHODS: This phase 3, multicenter, randomized,...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Pediatr Nephrol
Главные авторы: Greenbaum, Larry A., Jeck, Nikola, Klaus, Günter, Fila, Marc, Stoica, Cristina, Fathallah-Shaykh, Sahar, Paredes, Ana, Wickman, Larysa, Nelson, Raoul, Swinford, Rita D., Abitbol, Carolyn Larkins, Balgradean, Mihaela, Jankauskiene, Augustina, Perrin, Amandine, Enoiu, Milica, Ahn, Sun-Young
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Berlin Heidelberg 2020
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8009783/
https://ncbi.nlm.nih.gov/pubmed/33106892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-020-04805-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы